$CLS

Chawla Mandeep sold $324K of CLS

Chawla Mandeep (Chief Financial Officer) sold 883 shares of CELESTICA INC (CLS) at an average of $366.52 ($360.00–$374.03, $0.32M total) across 9 trades on 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chawla Mandeep
Published Aug 3, 2026, 10:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
high confidence
Mentioned
$CLS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

Insider selling under a pre-arranged plan is typically treated as low-signal; traders may monitor for patterns but usually do not reprice the stock on a single sale.

02

Market read

A routine 10b5-1 insider sale was filed, with no accompanying company-specific news.

03

What to watch

The sale size is modest relative to a large-cap issuer, and the 10b5-1 structure reduces the signal of timing or information advantage.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-03 after-hours; transaction dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica Inc.

Company-level read

Ticker impact

$CLSNeutralHigh confidence
Context

Celestica CFO Chawla Mandeep sold about $323.6K of CLS shares via an open-market sale under a 10b5-1 plan on 2026-07-31.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new guidance, contract, or regulatory development.

Market effects

No clear sector read-through from a single CFO 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can be interpreted as reduced confidence, though this specific disclosure lacks corroborating new fundamentals.

Key entities

  • Celestica Inc

    Subject of the Form 4 insider transaction disclosure (CLS).

  • Chawla Mandeep

    Chief Financial Officer who executed an open-market sale under a 10b5-1 plan.

Related articles

$CLSMedAI 8/10

Celestica Completes Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.

$CLSHighAI 9/10

Celestica Falls After Pricing $3 Bln Equity Offering

Celestica Inc. (CLS) shares fell nearly 12% after the company priced a $3.0 billion public equity offering. According to the company, it sold 9.68 million common shares at $310 each, raising expected gross proceeds of $3.0 billion, and gave underwriters a 30-day option for up to 1.45 million additional shares. CLS traded around $319.48, down about $43.28.

$CLSHighAI 9/10

Why is Celestica stock sliding today?

Celestica (CLS) shares fell 13.7% after the company priced a $3 billion common stock offering at $310 per share, down from the prior close of $362.76. Celestica plans to sell about 9.68 million treasury shares, with underwriters able to buy 1.45 million more. Management said the raise supports AI compute and networking demand.

$CLSMedAI 8/10

Celestica Announces Pricing of Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) priced an equity offering of 9,677,419 common shares at $310 per share. Gross proceeds are expected at about $3.0 billion before underwriting discounts and expenses. Underwriters have a 30-day option to buy up to 1,451,612 additional shares. Net proceeds will fund working capital and capital expenditures, among other purposes. Closing is expected around Aug. 7, 2026.